# Pre-Release VIVITROL for Opioid Dependent Inmates

> **NCT01563718** · PHASE4 · COMPLETED · sponsor: **Rhode Island Hospital** · enrollment: 26 (actual)

## Conditions studied

- Substance-Related Disorders

## Interventions

- **DRUG:** naltrexone for extended release injectable suspension

## Key facts

- **NCT ID:** NCT01563718
- **Lead sponsor:** Rhode Island Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2015-10-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01563718

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01563718, "Pre-Release VIVITROL for Opioid Dependent Inmates". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01563718. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*